---
title: "Viridian Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e22fa459-4dce-4c3b-9458-c9adf61efdac
json: https://whiteintel.dev/api/public/dossier/e22fa459-4dce-4c3b-9458-c9adf61efdac
identifier: gb-coh:4910486
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Viridian Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:4910486`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e22fa459-4dce-4c3b-9458-c9adf61efdac  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e22fa459-4dce-4c3b-9458-c9adf61efdac  

## Ownership & control

### Holdings / subsidiaries

- **VIRIDIAN THERAPEUTICS EUROPE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/72432352-77b0-5511-bdba-a3002a8a92eb

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Viridian Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/e22fa459-4dce-4c3b-9458-c9adf61efdac · Structured JSON: https://whiteintel.dev/api/public/dossier/e22fa459-4dce-4c3b-9458-c9adf61efdac._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._